Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GUARDIAN Australian Feasibility Study: Safety and Feasibility

NCT06962371 is registered in ClinicalTrials.gov with Transverse Medical, Inc. as lead sponsor.

NCT NCT06962371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06962371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GUARDIAN Australian Feasibility Study: Safety and Feasibility
Lead sponsor
Transverse Medical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
April 7, 2025
Completion date
March 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, transcatheter aortic valve implantation (tavi), transcatheter aortic valve replacement